Annual report pursuant to Section 13 and 15(d)

3. Acquisitions (Details Narrative)

v3.8.0.1
3. Acquisitions (Details Narrative)
12 Months Ended
Dec. 31, 2016
USD ($)
shares
Issuance of common stock in connection with completion of asset acquisition, value $ 34,902,444
Fair value of warrants issued 2,069,673
Asset Purchase Agreement [Member] | Pharmsynthez [Member]  
Fair value of asset acquired 39,500,000
Issuance of common stock in connection with completion of asset acquisition, value 38,600,000
Fair value of warrants issued 900,000
Debt converted, amount converted $ 6,500,000
Debt converted, shares issued | shares 1,400,000
Stock issued with closing of the APA | shares 3,000,000